Figure 3From: A 90Y-labelled anti-ROBO1 monoclonal antibody exhibits antitumour activity against hepatocellular carcinoma xenografts during ROBO1-targeted radioimmunotherapyAntitumour effect of90Y-anti-ROBO1 in mouse models. Tumour growth (%) (diamonds, saline; squares, cold-anti-ROBO1; triangles, 90Y anti-ROBO1).Back to article page